RLYB Rallybio Corporation

NASDAQ
$15.75

Rallybio Corporation (RLYB) is expected to report earnings on January 26, 2027, before the market open.

Rallybio Reported Earnings
Tuesday, October 27, 2026 · 12:00 AM ET
Earnings Date
Jan 26
Tuesday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Rallybio Corporation

Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.